Research Article
Phosphorylated mTOR Expression Profiles in Human Normal and Carcinoma Tissues
Table 2
Expression of p-mTOR in carcinoma tissues: a survey of 134 cases.
| Organ | Carcinomas | Total cases | p-mTOR (+) cases | Intensity |
| Stomach | Adenocarcinoma | 5 | 4 | ++ | Colon | Adenocarcinoma | 4 | 4 | +++ | Pancreas | Adenocarcinoma | 2 | 2 | +++ | Lung | Adenocarcinoma | 4 | 4 | ++ | | Squamous cell carcinoma | 3 | 1 | + | Liver | Hepatocellular carcinoma | 5 | 2 | ++ | Kidney | Renal cell carcinoma | 3 | 1 | ± | Bladder | Urothelial carcinoma | 102 | 23 | ++ | Skin | Squamous cell carcinoma | 2 | 2 | ++ | Lymph node | Metastatic hepatocellular carcinoma | 2 | 2 | +++ | | Metastatic renal cell carcinoma | 2 | 2 | +++ |
|
|
±: <5% positive cells; +: mild intensity in most cells; ++: moderate intensity in most cells; +++: strong intensity in most cells.
|